Besides being part of anti-Helicobacter pylori treatment regimens, proton pump inhibitors (PPIs) are increasingly being used to treat dyspepsia. However, little is known about the effects of PPIs on the human gastric microbiota, especially those related to H. pylori infection. The goal of this study was to characterize the stomach microbial communities in patients with dyspepsia and to investigate their relationships with PPI use and H. pylori status. Using 16S rRNA gene pyrosequencing, we analyzed the mucosa- associated microbial populations of 24 patients, of whom 12 were treated with the PPI omeprazole and 9 (5 treated and 4 untreated) were positive for H. pylori infection. The Proteobacteria, Firmicutes, Bacteroidetes, Fusobacteria, and Actinobacteria phyla accounted for 98% of all of the sequences, with Helicobacter, Streptococcus, and Prevotella ranking among the 10 most abundant genera. H. pylori infection or PPI treatment did not significantly influence gastric microbial species composition in dyspeptic patients. Principal-coordinate analysis of weighted UniFrac distances in these communities revealed clear but significant separation according to H. pylori status only. However, in PPI-treated patients, Firmicutes, particularly Streptococcaceae, were significantly increased in relative abundance compared to those in untreated patients. Consistently, Streptococcus was also found to significantly increase in relation to PPI treatment, and this increase seemed to occur independently of H. pylori infection. Our results suggest that Streptococcus may be a key indicator of PPI-induced gastric microbial composition changes in dyspeptic patients. Whether the gastric microbiota alteration contributes to dyspepsia needs further investigation.

Sterbini, F. P., Palladini, A., Masucci, L., Cannistraci, C. V., Pastorino, R., Ianiro, G., Bugli, F., Martini, C., Ricciardi, G., Gasbarrini, A., Sanguinetti, M., Cammarota, G., Posteraro, B., Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients, <<APPLIED AND ENVIRONMENTAL MICROBIOLOGY>>, 2016; 82 (22): 6633-6644. [doi:10.1128/AEM.01437-16] [http://hdl.handle.net/10807/92110]

Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients

Masucci, Luca;Pastorino, Roberta;Ianiro, Gianluca;Bugli, Francesca;Martini, Cecilia;Ricciardi, Gualtiero;Gasbarrini, Antonio;Sanguinetti, Maurizio
;
Cammarota, Giovanni
Penultimo
;
Posteraro, Brunella
Ultimo
2016

Abstract

Besides being part of anti-Helicobacter pylori treatment regimens, proton pump inhibitors (PPIs) are increasingly being used to treat dyspepsia. However, little is known about the effects of PPIs on the human gastric microbiota, especially those related to H. pylori infection. The goal of this study was to characterize the stomach microbial communities in patients with dyspepsia and to investigate their relationships with PPI use and H. pylori status. Using 16S rRNA gene pyrosequencing, we analyzed the mucosa- associated microbial populations of 24 patients, of whom 12 were treated with the PPI omeprazole and 9 (5 treated and 4 untreated) were positive for H. pylori infection. The Proteobacteria, Firmicutes, Bacteroidetes, Fusobacteria, and Actinobacteria phyla accounted for 98% of all of the sequences, with Helicobacter, Streptococcus, and Prevotella ranking among the 10 most abundant genera. H. pylori infection or PPI treatment did not significantly influence gastric microbial species composition in dyspeptic patients. Principal-coordinate analysis of weighted UniFrac distances in these communities revealed clear but significant separation according to H. pylori status only. However, in PPI-treated patients, Firmicutes, particularly Streptococcaceae, were significantly increased in relative abundance compared to those in untreated patients. Consistently, Streptococcus was also found to significantly increase in relation to PPI treatment, and this increase seemed to occur independently of H. pylori infection. Our results suggest that Streptococcus may be a key indicator of PPI-induced gastric microbial composition changes in dyspeptic patients. Whether the gastric microbiota alteration contributes to dyspepsia needs further investigation.
Inglese
Sterbini, F. P., Palladini, A., Masucci, L., Cannistraci, C. V., Pastorino, R., Ianiro, G., Bugli, F., Martini, C., Ricciardi, G., Gasbarrini, A., Sanguinetti, M., Cammarota, G., Posteraro, B., Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients, <<APPLIED AND ENVIRONMENTAL MICROBIOLOGY>>, 2016; 82 (22): 6633-6644. [doi:10.1128/AEM.01437-16] [http://hdl.handle.net/10807/92110]
File in questo prodotto:
File Dimensione Formato  
Appl. Environ. Microbiol.-2016-Paroni Sterbini-6633-44.pdf

non disponibili

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 1.4 MB
Formato Unknown
1.4 MB Unknown   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/92110
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 60
  • ???jsp.display-item.citation.isi??? 55
social impact